Review: Antioxidant therapeutic advances in COPD
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Chronic obstructive pulmonary disease (COPD) is associated with a high incidence of morbidity and mortality. Cigarette smoke-induced oxidative stress is intimately associated with the progression and exacerbation of COPD and therefore targeting oxidative stress with antioxidants or boosting the endogenous levels of antioxidants is likely to have beneficial outcome in the treatment of COPD. Among the various antioxidants tried so far, thiol antioxidants and mucolytic agents, such as glutathione, N-acetyl-L-cysteine, N-acystelyn, erdosteine, fudosteine and carbocysteine; Nrf2 activators; and dietary polyphenols (curcumin, resveratrol, and green tea catechins/quercetin) have been reported to increase intracellular thiol status along with induction of GSH biosynthesis. Such an elevation in the thiol status in turn leads to detoxification of free radicals and oxidants as well as inhibition of ongoing inflammatory responses. In addition, specific spin traps, such as α-phenyl-N-tert-butyl nitrone, a catalytic antioxidant (ECSOD mimetic), porphyrins (AEOL 10150 and AEOL 10113), and a SOD mimetic M40419 have also been reported to inhibit cigarette smoke-induced inflammatory responses in vivo in the lung. Since a variety of oxidants, free radicals and aldehydes are implicated in the pathogenesis of COPD, it is possible that therapeutic administration of multiple antioxidants and mucolytics will be effective in management of COPD. However, a successful outcome will critically depend upon the choice of antioxidant therapy for a particular clinical phenotype of COPD, whose pathophysiology should be first properly understood. This article will review the various approaches adopted to enhance lung antioxidant levels, antioxidant therapeutic advances and recent past clinical trials of antioxidant compounds in COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1
Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., & Ichijo, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2596 · Cited by 2,377 · cited 1×
“Thioredoxin has been reported to associate with other proteins such as hepatopoietin [Li et al. 2005] and the apoptosis signal regulating kinase, ASK-1 [Saitoh et al. 1998] as heterodimeric complexes.”
BackgroundPolyphenols and disease risk in epidemiologic studies
Arts, I. C., & Hollman, P. C. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.317s · Cited by 1,916 · cited 2×
“Polyphenols Several epidemiological studies have established a beneficial link between polyphenol intake and reduced risk of disease, which were attributed to both the antioxidant and anti-inflammatory properties of polyphenols [Arts and Hollman, 2005].”
BackgroundSystemic oxidative stress in asthma, COPD, and smokers
Rahman, I., Morrison, D., Donaldson, K., & MacNee, W. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.4.8887607 · Cited by 774 · cited 6×
“However, other enzyme systems are also used, such as the xanthine/xanthine oxidase system and the heme peroxidases, levels of which are elevated in COPD patients [Rahman et al. 1996; Pinamonti et al. 1998; Aaron et al. 2001; Gompertz et al. 2001].”
BackgroundInfluentialDisruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice
Rangasamy, T., Guo, J., Mitzner, W. A., Roman, J., Singh, A., Fryer, A. D., Yamamoto, M., Kensler, T. W., Tuder, R. M., Georas, S. N., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050538 · Cited by 580 · cited 2×
“Nrf2 deficient (Nrf2 − / − ) mice have been shown to be more susceptible to airway inflammation caused by bleomycin [Cho et al. 2004], ovalbumin challenge [Rangasamy et al. 2005] and hyperoxia [Hayes and McLellan 1999].”
BackgroundRahman, I., Marwick, J., & Kirkham, P. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.042 · Cited by 507 · cited 3×
“Glucocorticoid suppression of inflammatory genes requires recruitment of histone deacetylase-2 (HDAC2) to the transcription activation complex by the glucocorticoid receptor [Rahman et al. 2004; Ito et al. 2001].”
BackgroundSelf-citationKode, A., Rajendrasozhan, S., Caito, S., Yang, S.-R., Megson, I. L., & Rahman, I. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00361.2007 · Cited by 447 · cited 4×
“tional modifications of Nrf2 and Keap1 caused by aldehydes present in CSE [Kode et al. 2008].”
BackgroundInfluentialSelf-citationOxidative stress and airway inflammation in severe exacerbations of COPD
Drost, E. M. (2005) · Thorax · doi:10.1136/thx.2004.027946 · Cited by 389 · cited 2×
“cytokines and decreased GSH levels were observed in patients with COPD than in healthy non-smokers [Drost et al. 2005].”
BackgroundDiet and obstructive lung diseases
Romieu, I., & Trenga, C. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000806 · Cited by 324 · cited 2×
“These studies show depletion of ascorbic acid, vitamin E, β -carotene and selenium in the serum of chronic smokers and in patients with COPD [Duthie et al. 1991; Antwerpen et al. 1993; Bridges et al. 1993; Mezzetti et al. 1995; Romieu and Trenga 2001; Couillard et al. 2002; Tug et al. 2004].”
BackgroundSuzuki, M., Betsuyaku, T., Ito, Y., Nagai, K., Nasuhara, Y., Kaga, K., Kondo, S., & Nishimura, M. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0424oc · Cited by 286 · cited 1×
“…clearly highlighted the downregulation of Nrf2 (GSH levels) in pulmonary macrophages and in lungs of patients with COPD via loss of GCL and Nrf2 positive regulator DJ-1 and post-translational modifications of Keap1-Bach1 equilibrium [Malhotra et al. 2008; Goven et al. 2008; Suzuki et al. 2008].”
BackgroundKASIELSKI, M., & NOWAK, D. (2001) · Respiratory Medicine · doi:10.1053/rmed.2001.1066 · Cited by 179
Effects of smoking and vitamin E on blood antioxidant status
Duthie, G., Arthur, Jr., & James, W. P. T. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.4.1061s · Cited by 162 · cited 2×
“Depletion of total antioxidant capacity in smokers is associated with decreased levels of major plasma antioxidants in smokers [Petruzzelli et al. 1990; Duthie et al. 1991; Antwerpen et al. 1993; Bridges et al. 1993; Mezzetti et al. 1995; Rahman and MacNee 1996].”
BackgroundPotential Therapeutic Effect of Antioxidant Therapy in Shock and Inflammation
Cuzzocrea, S., Thiemermann, C., & Salvemini, D. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365396 · Cited by 129
Gillissen, A., Jaworska, M., Orth, M., Coffiner, M., Maes, P., App, E. M., Cantin, A. M., & Schultze-Werninghaus, G. (1997) · Respiratory Medicine · doi:10.1016/s0954-6111(97)90052-4 · Cited by 116
Cited by
Curcumin—From Molecule to Biological Function
Esatbeyoglu, T., Huebbe, P., Ernst, I. M. A., Chin, D., Wagner, A. E., & Rimbach, G. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107724 · Cited by 904
The structural biochemistry of the superoxide dismutases
Perry, J. J. P., Shin, D. S., Getzoff, E. D., & Tainer, J. A. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.11.004 · Cited by 562
Role of NADPH oxidase/ROS in pro-inflammatory mediators-induced airway and pulmonary diseases
Lee, I.-T., & Yang, C.-M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.05.005 · Cited by 424
Natural and synthetic antioxidants: An updated overview
Augustyniak, A., Bartosz, G., Čipak, A., Duburs, G., Horáková, L., Łuczaj, W., Majekova, M., Odysseos, A. D., Rackova, L., Skrzydlewska, E., et al. (2010) · Free Radical Research · doi:10.3109/10715762.2010.508495 · Cited by 319
Singh, S., Vrishni, S., Singh, B. K., Rahman, I., & Kakkar, P. (2010) · Free Radical Research · doi:10.3109/10715762.2010.507670 · Cited by 293
Self-citation
Metadata
- Authors
- Rahman, I.
- Venue
- Therapeutic Advances in Respiratory Disease
- Publisher
- SAGE Publications
- Published
- 2008-12
- Volume
- 2
- Issue
- 6
- Pages
- 351-374
- ISSN
- 1753-4658 (ISSN-L)
- 1753-4666
- OpenAlex
- W2160967657
- Cited by
- 123
- References
- 13
- FWCI
- 14.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.